Despite our initial observations of an association between cerebrovascular disease and AD diagnosis26, it is unclear at what age cerebrovascular features typically arise in adults with Down syndrome and how the temporal evolution of cerebrovascular disease compares with other AD biomarkers, like amyloid and tau. The gene discussed is MAPT; the disease is cerebrovascular disorder.